✦ LIBER ✦

Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer

✍ Scribed by Mariana Chavez-MacGregor; Erika Brown; Xiudong Lei; Jennifer Litton; Funda Meric-Bernstram; Elizabeth Mettendorf; Leonel Hernandez; Vicente Valero; Gabriel N. Hortobagyi; Ana Maria Gonzalez-Angulo

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 187 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26144

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pathologic complete response in breast c

Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy : Evaluating the effect of race/ethnicity

✍ Mariana Chavez-MacGregor; Jennifer Litton; Huiqin Chen; Sharon H. Giordano; Clif 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 2 views

MRI evaluation of pathologically complet

MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy

✍ Jeon Hor Chen; Byon Feig; Garima Agrawal; Hon Yu; Philip M. Carpenter; Rita S. M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 2 views

## Abstract ## BACKGROUND. This study investigated the role of magnetic resonance imaging (MRI) in evaluation of pathologically complete response and residual tumors in patients who were receiving neoadjuvant chemotherapy (NAC) for both positive and negative HER‐2 breast cancer. ## METHODS. Fift

Quality of pathologic response and surge

Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy

✍ Guru Sonpavde; Bryan H. Goldman; V. O. Speights; Seth P. Lerner; David P. Wood; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

The safety of breast-conserving surgery

The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy

✍ Florentia Peintinger; W. Fraser Symmans; Ana M. Gonzalez-Angulo; Judy C. Boughey 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

MRI measurements of tumor size and pharm

MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy

✍ Hon J. Yu; Jeon-Hor Chen; Rita S. Mehta; Orhan Nalcioglu; Min-Ying Su 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

## Abstract ## Purpose To investigate the value of using changes in three parameters (tumor size, transfer constant (K^trans^), and rate constant (k~ep~)) obtained after the first treatment‐cycle in predicting the final clinical response after two to four cycles of neoadjuvant anthracycline and cy

Hormonal receptors in locally advanced b

Hormonal receptors in locally advanced breast cancer: Change with response to neoadjuvant chemotherapy?

✍ Don M. Morris; Jackie Edwards; Frank Gelder 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## Abstract Twenty‐one cancers in 20 patients with locally advanced breast cancer were studied. Incisional biopsy was performed without using electrocautery. Tissue was obtained for histology and estrogen (ER) and progesterone (PR) receptors. Patients received chemotherapy after biopsy. All respond